|
|
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes
Pierre Bigot
,
Jean-François Hétet
,
Jean-Christophe Bernhard
,
Tarek Fardoun
,
François Audenet
et al.
Journal articles
hal-01064296v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy
,
Emmanuelle Le Chatelier
,
Lisa Derosa
,
Connie Duong
,
Maryam Tidjani Alou
et al.
Journal articles
hal-02126484v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program
Laurence Albiges
,
Aude Fléchon
,
Christine Chevreau
,
Delphine Topart
,
Gwenaëlle Gravis
et al.
Journal articles
hal-03623382v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma
Elodie Jobard
,
Ellen Blanc
,
Sylvie Négrier
,
Bernard Escudier
,
Gwenaëlle Gravis
et al.
Journal articles
hal-01234309v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study
Philippe Paparel
,
Pierre Bigot
,
Xavier Matillon
,
Karim Bensalah
,
Laurent Salomon
et al.
Journal articles
istex
hal-01064319v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry
,
Cécile Dalban
,
Nathalie Rioux-Leclercq
,
Julien Adam
,
Maxime Meylan
et al.
Journal articles
hal-03477307v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
François Ghiringhelli
,
Cédric Ménard
,
Magali Terme
,
Caroline Flament
,
Julien Taieb
et al.
Journal articles
pasteur-00020140v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Ronan Flippot
,
Cécile Dalban
,
Brigitte Laguerre
,
Delphine Borchiellini
,
Gwénaelle Gravis
et al.
Journal articles
hal-02931819v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurélie Fluckiger
,
Romain Daillere
,
Mohamed Sassi
,
Barbara S Sixt
,
Peng Liu
et al.
Journal articles
inserm-02923397v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer
Florence Joly
,
Natacha Heutte
,
Brigitte Duclos
,
Sabine Noal
,
Isabelle Léger-Hardy
et al.
Journal articles
hal-01893539v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Avancées et synthèse des derniers congrès : ASCO-GU, EAU, AUA, ASCO concernant la prise en charge médicale du cancer du rein localement avancé ou métastatique. [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]
Jean-Jacques Patard
,
Bernard Escudier
,
Philippe Paparel
,
Yann Neuzillet
,
Jean-Alexandre Long
et al.
Journal articles
inserm-00489823v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa
,
Bertrand Routy
,
Marine Fidelle
,
V.Alerio Iebba
,
Laurie Alla
et al.
Journal articles
hal-02569488v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study
Cedric Lebacle
,
Karim Bensalah
,
Jean-Christophe Bernhard
,
Laurence Albiges
,
Brigitte Laguerre
et al.
Journal articles
hal-03885560v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Membrane-Bound Interleukin (IL)-15 on Renal Tumor Cells Rescues Natural Killer Cells from IL-2 Starvation-Induced Apoptosis.
Sebastian Wittnebel
,
Sylvie da Rocha
,
Julien Giron-Michel
,
Abdelali Jalil
,
Paule Opolon
et al.
Journal articles
hal-00158208v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Kystes atypiques et tumeurs kystiques du rein : considérations anatomopathologiques, radiologiques et chirurgicales. Conclusions du forum AFU 2007. [Atypical cysts and cystic tumours of the kidney: Histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum.]
Jean-Alexandre Long
,
Yann Neuzillet
,
Jean-Michel Corréas
,
Marc de Fromont
,
Hervé Lang
et al.
Journal articles
inserm-00355977v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array
Laurence Albiges
,
Justine Guegan
,
Audrey Le Formal
,
Virginie Verkarre
,
Nathalie Rioux-Leclercq
et al.
Journal articles
hal-01064619v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status
Yosra Messai
,
Sophie Gad
,
Muhammad Zaeem Noman
,
Gwenael Le Teuff
,
Sophie Couve
et al.
Journal articles
hal-01255838v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies
Angeline Denouel
,
Natacha Heutte
,
Bernard Escudier
,
Jean-Emmanuel Kurtz
,
Mélanie dos Santos
et al.
Journal articles
hal-02280077v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
Helena Polena
,
Julie Creuzet
,
Maeva Dufies
,
Adama Sidibé
,
Abir Khalil-Mgharbel
et al.
Journal articles
hal-02005080v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Novel FH mutations in families with hereditary leiomyomatosis renal cell cancer (HLRCC) and in patients with isolated type 2 papillary renal cell carcinoma
Betty Gardie
,
Audrey Remenieras
,
Darouna Kattygnarath
,
Johny Bombled
,
Sandrine Lefèvre
et al.
Journal articles
hal-00614499v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
Pierre Bigot
,
Tarek Fardoun
,
Jean Christophe Bernhard
,
Evanguelos Xylinas
,
Julien Berger
et al.
Journal articles
hal-01064633v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
Philippe Rochigneux
,
Jeanne Thomassin-Piana
,
Sophy Laibe
,
Serge Brunelle
,
Naji Salem
et al.
Journal articles
hal-03689938v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Isolation and characterization of renal cancer stem cells from patient-derived xenografts
Meriem Hasmim
,
Stefania Bruno
,
Sandy Azzi
,
Cindy Gallerne
,
Julien Giron Michel
et al.
Journal articles
hal-02069078v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto-Ballotti
,
Fabienne Lesueur
,
Sandy Giuliano
,
Thomas Strub
,
Mahaut de Lichy
et al.
Journal articles
istex
hal-00719536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|